Submitted by Anonymous (not verified) on 26 June 2025 - 15:45
Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation: 23/08/2018, Revision: 22, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation: 23/08/2018, Revision: 22, Status: Authorised